Long Acting Injectable, Cabotegravir (CAB-LA) Overview
| Name | BUSOGA HEALTH FORUM |
|---|
| Activity Title | Long Acting Injectable, Cabotegravir (CAB-LA) Overview |
|---|
| Details | Cabotegravir (CAB-LA) is a long-acting injectable antiretroviral used for HIV prevention. Administered every two months, it provides an effective alternative to daily oral PrEP. CAB-LA improves adherence, reduces new HIV infections, and supports broader prevention efforts, especially among high-risk populations. |
|---|
| Competence | Internal Medicine |
|---|
| Start Date | 14-10-2025 |
|---|
| End Date | 14-10-2025 |
|---|
| Event Time | 04:45 PM |
|---|
| Location | Zoom |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 2 |
|---|